D-0086-2024 Class II Terminated
FDA drug recall D-0086-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 13, 2023 and is designated Class II. Reason for recall: Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg. The recall status is terminated (terminated Sep 9, 2024). Affected quantity: 1,656 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 15, 2023
- Initiation Date
- Oct 13, 2023
- Termination Date
- Sep 9, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,656 bottles
Product description
Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories., Princeton, NJ 08540, Made in India, NDC# 55111-725-10.
Reason for recall
Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.
Distribution pattern
Nationwide
Code information
Lot # C2305569, Exp. date 03/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0086-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026